Back to VTIV
inVentiv Commercial Selected to Provide Sales and Training for BTG

SOMERSET, N.J., Oct. 25, 2010 (GLOBE NEWSWIRE) -- inVentiv Commercial, a division of inVentiv Health and the industry leader in outsourced sales teams to the pharmaceutical industry, announced today that it has been selected by international specialty pharmaceuticals company BTG International Inc to provide a sales team, as well as training and fulfillment services, for the company's CroFab® and DigiFab® products. CroFab® is an antidote used to treat envenomation from Crotalid snakes, and DigiFab® is a treatment for life-threatening digoxin (digitalis) toxicity or overdose.

"inVentiv is extremely pleased to be collaborating with BTG," said Eric Sirota, President of inVentiv Commercial. "We look forward to putting our experienced sales teams and expert training and fulfillment services to work for CroFab® and DigiFab®, vitally important products for toxicity and venom treatment."

"We look forward to working with inVentiv Commercial," said Dan Schneider, Vice President of Sales & Marketing, BTG. "Their experience in recruiting and deploying high-quality sales teams will be an asset to BTG as we focus on promoting these important products."

About inVentiv Health

inVentiv Health, Inc. is a leading, global provider of data-driven, outsourced solutions to the pharmaceutical, life sciences and healthcare industries. inVentiv's full suite of marketing, sales, clinical development and post-approval solutions drive speed and effectiveness across all phases of the product lifecycle, leading to quicker development and superior results throughout product launch and commercialization. inVentiv's client roster consists of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payer companies. For more information, visit

The inVentiv Health, Inc. logo is available at

CONTACT:  inVentiv Health, Inc.
          Joe Massaro, CFO
            (732) 537-4804
          Marcia Frederick
            (614) 543-6281

company logo

Back to VTIV
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki